Bandingkan Harga & Kinerja Bima Sakti Pertiwi Tbk. (PAMG) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bima Sakti Pertiwi Tbk. dan Organon Pharma Indonesia Tbk.: Bima Sakti Pertiwi Tbk. diperdagangkan di Rp56 (kapitalisasi pasar 175 M, volume 24 jam 6,26 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bima Sakti Pertiwi Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| PAMG | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 175 M | 104,4 M |
Volume | 6,26 jt | — |
Lot | 62,6 rb | — |
Perputaran | 346,31 jt | — |
Harga Rata-rata | 55,32 | — |
Nilai Transaksi | 346,31 jt | — |
Harga Ekuilibrium Indikatif | 56 | — |
Volume Ekuilibrium Indikatif | 2,3 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bima Sakti Pertiwi Tbk.
PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.
Selengkapnya di halaman PAMG →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
